, June 5 -- The Bangladesh Association of Pharmaceuticals Industries (BAPI) views the proposed extension and enhancement of duty and tax exemptions on the import of raw materials for the pharmaceutical sector in the FY2025-26 budget as a positive move.

The association in a press release said such decisions by the government will further strengthen the country's pharmaceutical industry.

The proposed duty exemptions for importing raw materials used in Active Pharmaceutical Ingredients (API) will significantly help develop the API industry, it said.

BAPI also expresses hope that the pharmaceutical sector, with some additional incentives, can emerge not only as a key supplier for the domestic market but also as a major export-oriented indu...